Philippe Camus

Summary

Affiliation: CHU de Dijon
Country: France

Publications

  1. ncbi Amiodarone pulmonary toxicity
    Philippe Camus
    Department of Pulmonary Medicine and Critical Care, Centre Hospitalier et Université de Bourgogne, F 2100 Dijon, France
    Clin Chest Med 25:65-75. 2004
  2. pmc Interstitial lung disease associated with drug therapy
    P Camus
    Services de Pneumologie, University Hospital and Medical School, Universite de Bourgogne, Dijon, France
    Br J Cancer 91:S18-23. 2004
  3. ncbi Drug-induced respiratory disease in patients with hematological diseases
    Philippe Camus
    Department of Pulmonary Medicine, Hopital Le Bocage, Dijon, France
    Semin Respir Crit Care Med 26:458-81. 2005
  4. ncbi [Drug-induced lung diseases]
    Philippe Camus
    Service de Pneumologie et de Reanimation Respiratoire, Hopital du Bocage, 21000 Dijon
    Rev Prat 57:2249-57. 2007
  5. ncbi Iatrogenic lung disease
    Philippe Camus
    Pulmonary and Critical Care Medicine, Centre Hospitalier Régional et Université de Bourgogne, F 21079 Dijon, France
    Clin Chest Med 25:XIII-XIX. 2004
  6. ncbi [Iatrogenic respiratory complications of cardiovascular drugs]
    Ph Camus
    Service de Pneumologie et de Reanimation Respiratoire, CHU Le Bocage Dijon
    Rev Mal Respir 20:S65-73. 2003
  7. ncbi Interstitial lung disease induced by drugs and radiation
    Philippe Camus
    Department of Pulmonary and Intensive Care, University Medical Center Le Bocage and Medical School, Universite de Bourgogne, Dijon, France
    Respiration 71:301-26. 2004
  8. ncbi Drug-induced and iatrogenic infiltrative lung disease
    Philippe Camus
    Department of Pulmonary Disease and Intensive Care, Hopital du Bocage, Faculté de Médecine at Université de Bourgogne, 2 Bd Marechal de Lattre de Tasigny, 21034 Dijon Cedex, France
    Clin Chest Med 25:479-519, vi. 2004
  9. pmc Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management
    P Camus
    Services de Pneumologie, University Hospital and Medical School, Universite de Bourgogne, Dijon, France
    Br J Cancer 91:S1-2. 2004
  10. ncbi Salbutamol, terbutaline and pirbuterol allergy in an asthmatic patient
    P Bonniaud
    Department of Pulmonary Medicine and Critical Care, Centre Hospitalier Universitaire du Bocage et Faculté de Médecine, 21079 Dijon, France
    Allergy 62:1219-20. 2007

Detail Information

Publications16

  1. ncbi Amiodarone pulmonary toxicity
    Philippe Camus
    Department of Pulmonary Medicine and Critical Care, Centre Hospitalier et Université de Bourgogne, F 2100 Dijon, France
    Clin Chest Med 25:65-75. 2004
    ..Amiodarone remains difficult to diagnose noninvasively, and although the outcome is good in the majority of patients, not all cases of APT can be controlled satisfactorily...
  2. pmc Interstitial lung disease associated with drug therapy
    P Camus
    Services de Pneumologie, University Hospital and Medical School, Universite de Bourgogne, Dijon, France
    Br J Cancer 91:S18-23. 2004
    ..However, the difference remains unexplained, leaving important epidemiological and mechanistic questions...
  3. ncbi Drug-induced respiratory disease in patients with hematological diseases
    Philippe Camus
    Department of Pulmonary Medicine, Hopital Le Bocage, Dijon, France
    Semin Respir Crit Care Med 26:458-81. 2005
    ..This review discusses the myriad causes of lung injury/toxicity that may afflict patients with hematological malignancies or transplant recipients, and presents diagnostic and therapeutic approaches...
  4. ncbi [Drug-induced lung diseases]
    Philippe Camus
    Service de Pneumologie et de Reanimation Respiratoire, Hopital du Bocage, 21000 Dijon
    Rev Prat 57:2249-57. 2007
    ..g. amiodarone). There is no definite diagnostic criterion, the final diagnosis relying on the clinical and imaging features, the chronology of pulmonary manifestations, and the prevalence of reported cases with the suspected drug...
  5. ncbi Iatrogenic lung disease
    Philippe Camus
    Pulmonary and Critical Care Medicine, Centre Hospitalier Régional et Université de Bourgogne, F 21079 Dijon, France
    Clin Chest Med 25:XIII-XIX. 2004
  6. ncbi [Iatrogenic respiratory complications of cardiovascular drugs]
    Ph Camus
    Service de Pneumologie et de Reanimation Respiratoire, CHU Le Bocage Dijon
    Rev Mal Respir 20:S65-73. 2003
  7. ncbi Interstitial lung disease induced by drugs and radiation
    Philippe Camus
    Department of Pulmonary and Intensive Care, University Medical Center Le Bocage and Medical School, Universite de Bourgogne, Dijon, France
    Respiration 71:301-26. 2004
    ..Rechallenge is justified in a minority of patients, and is discouraged for diagnostic purposes only. Pneumotox (www.pneumotox.com) provides updated information on drug-induced respiratory disease...
  8. ncbi Drug-induced and iatrogenic infiltrative lung disease
    Philippe Camus
    Department of Pulmonary Disease and Intensive Care, Hopital du Bocage, Faculté de Médecine at Université de Bourgogne, 2 Bd Marechal de Lattre de Tasigny, 21034 Dijon Cedex, France
    Clin Chest Med 25:479-519, vi. 2004
    ..Infiltrative lung disease (ILD) is the most common pattern of drug-induced injury. This article, which is clinically oriented rather than drug oriented, reviews the patterns of ILD produced by therapeutic drugs and radiation therapy...
  9. pmc Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management
    P Camus
    Services de Pneumologie, University Hospital and Medical School, Universite de Bourgogne, Dijon, France
    Br J Cancer 91:S1-2. 2004
  10. ncbi Salbutamol, terbutaline and pirbuterol allergy in an asthmatic patient
    P Bonniaud
    Department of Pulmonary Medicine and Critical Care, Centre Hospitalier Universitaire du Bocage et Faculté de Médecine, 21079 Dijon, France
    Allergy 62:1219-20. 2007
  11. ncbi [Leak monitoring in noninvasive ventilation]
    C A Rabec
    Service de Pneumologie et Reanimation Respiratoire, Centre Hospitalier et Universitaire de Dijon, Dijon, France
    Arch Bronconeumol 40:508-17. 2004
    ..If leaks can be detected during treatment, the probable cause of treatment failure can sometimes be established and possible pathophysiological mechanisms better understood. With this knowledge, it may be possible to improve ventilation...
  12. ncbi [Difficult weaning due to tracheal compression by an esophageal bezoar]
    C Rabec
    Service de Pneumologie et Reanimation Respiratoire, CHU Dijon, France
    Rev Mal Respir 25:333-7. 2008
    ..It is a rare condition, which is favoured by a reduction in intestinal motility, or by a primary abnormality reducing the patency of gastrointestinal tract...
  13. ncbi [Pulmonary embolism by cyanoacrylate following embolisation of an arteriovenous malformation]
    N Favrolt
    Service de Pneumologie et Reanimation Respiratoire, CHU de Dijon, France
    Rev Mal Respir 26:74-7. 2009
    ..Symptomatic complications can occur after intravascular injection of cyanoacrylate glue. We report a case of pulmonary embolism following embolisation of an arteriovenous malformation (AVM)...
  14. doi Evaluating noninvasive ventilation using a monitoring system coupled to a ventilator: a bench-to-bedside study
    C Rabec
    Service de Pneumologie et Reanimation Respiratoire, Centre Hospitalier et Universitaire de Dijon, Dijon, France
    Eur Respir J 34:902-13. 2009
    ..5%). In 15.7% of cases, when abnormalities persisted, a polygraphy was performed. The systematic use of this device enables NIV to be optimised, limiting the indication of sleep studies to complex cases...
  15. ncbi Metabolism of nilutamide in rat lung
    Kjetil Ask
    Laboratory of Pulmonary Pharmacology and Toxicology, UMR INRA Université de Bourgogne 1234, Faculte de Medecine et de Pharmacie, Dijon, France
    Biochem Pharmacol 71:377-85. 2006
    ..In accordance with recent findings, subcellular localization, oxygen sensitivity, cofactor requirements and inhibitor studies lead us to suggest the involvement of a soluble nitric oxide synthase in lung cytosolic nitroreduction...
  16. ncbi Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma
    Alyn H Morice
    Respiratory Medicine, Academic Medicine, University of Hull, Castle Hill Hospital, Castle Road, Cottingham, East Yorkshire HU16 5JQ, UK
    Pulm Pharmacol Ther 21:32-9. 2008
    ..The novel HFA pMDI formulation of budesonide/formoterol is an equally well tolerated and effective treatment for adults and adolescents with asthma as the budesonide/formoterol DPI...